Novel research found that apparent resistant hypertension (aRH) prevalence was lower in a real-world sample than previously reported, but still relatively frequent -- affecting nearly 1 in 10 ...

Resistant hypertension is a serious form of high blood pressure that persists despite the use of at least three antihypertensive medications from different classes, including a diuretic. In a recent ...

Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...

Findings showed treatment with lorundrostat resulted in statistically significant reductions in systolic blood pressure compared with placebo. Topline data were announced from a phase 3 trial ...

Please provide your email address to receive an email when new articles are posted on . Clinicians must carefully rule out other conditions before diagnosing resistant hypertension. Drug- and ...